Report predicts strong PET growth
A report by Frost & Sullivan predicts that positron emissiontomography's share of the worldwide market for cancer imagingand therapy equipment will grow rapidly in coming years. PET revenues will constitute 15% of the total market for suchequipment
A report by Frost & Sullivan predicts that positron emissiontomography's share of the worldwide market for cancer imagingand therapy equipment will grow rapidly in coming years.
PET revenues will constitute 15% of the total market for suchequipment by 2000, compared to 1% in 1993. PET's share of revenuesin the cancer imaging and therapy equipment market at that timewill match that of CT, which is expected to decline to 15%, comparedto 24% in 1993.
The market as a whole will grow at a 7% compound annual rate,from $2.74 billion in 1993 to $4.44 billion in 2000, accordingto the report, entitled World Cancer Diagnostic Imaging and TherapeuticEquipment Markets.
FDA Clears Virtually Helium-Free 1.5T MRI System from Siemens Healthineers
June 26th 2025Offering a cost- and resource-saving DryCool magnet technology, the Magnetom Flow.Ace MRI system reportedly requires 0.7 liters of liquid helium for cooling over the lifetime of the device in contrast to over 1,000 liters commonly utilized with conventional MRI platforms.
SNMMI: Botox May Facilitate Relief from Dry Mouth Side Effect of PSMA-Targeted Radiopharmaceuticals
June 25th 2025For patients being treated with radiopharmaceutical agents for metastatic prostate cancer, the combination of botulinum toxin and an anti-nausea patch led to a 30 percent reduction in PSMA uptake in the salivary glands, according to preliminary research findings presented at the SNMMI conference.
